Ocugen Inc (OCGN)
0.9272
+0.03
(+2.92%)
USD |
NASDAQ |
Nov 22, 12:02
Ocugen 1 Year Total Returns (Daily): 132.8% for Nov. 21, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
November 21, 2024 | 132.8% |
November 20, 2024 | 124.1% |
November 19, 2024 | 124.7% |
November 18, 2024 | 134.4% |
November 15, 2024 | 147.3% |
November 14, 2024 | 167.4% |
November 13, 2024 | 162.5% |
November 12, 2024 | 183.4% |
November 11, 2024 | 197.3% |
November 08, 2024 | 156.6% |
November 07, 2024 | 184.5% |
November 06, 2024 | 162.4% |
November 05, 2024 | 146.8% |
November 04, 2024 | 148.7% |
November 01, 2024 | 165.1% |
October 31, 2024 | 147.6% |
October 30, 2024 | 170.6% |
October 29, 2024 | 168.3% |
October 28, 2024 | 181.3% |
October 25, 2024 | 146.2% |
October 24, 2024 | 126.1% |
October 23, 2024 | 127.5% |
October 22, 2024 | 132.5% |
October 21, 2024 | 134.6% |
October 18, 2024 | 121.3% |
Date | Value |
---|---|
October 17, 2024 | 118.3% |
October 16, 2024 | 116.9% |
October 15, 2024 | 126.3% |
October 14, 2024 | 127.0% |
October 11, 2024 | 131.2% |
October 10, 2024 | 110.8% |
October 09, 2024 | 132.5% |
October 08, 2024 | 135.4% |
October 07, 2024 | 143.8% |
October 04, 2024 | 149.4% |
October 03, 2024 | 132.2% |
October 02, 2024 | 142.3% |
October 01, 2024 | 137.5% |
September 30, 2024 | 148.0% |
September 27, 2024 | 150.8% |
September 26, 2024 | 143.1% |
September 25, 2024 | 156.2% |
September 24, 2024 | 144.0% |
September 23, 2024 | 160.0% |
September 20, 2024 | 180.6% |
September 19, 2024 | 183.7% |
September 18, 2024 | 180.0% |
September 17, 2024 | 173.7% |
September 16, 2024 | 185.9% |
September 13, 2024 | 176.1% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-99.16%
Minimum
Nov 25 2019
5.59K%
Maximum
Nov 02 2021
406.1%
Average
-65.15%
Median
1 Year Total Returns (Daily) Benchmarks
Cytokinetics Inc | 50.19% |
Scholar Rock Holding Corp | 124.9% |
Mirum Pharmaceuticals Inc | 35.88% |
SpringWorks Therapeutics Inc | 71.63% |
NeuroBo Pharmaceuticals Inc | -31.69% |